Artiva Biotherapeutics, Inc.
ARTV
18 insider filings · Latest: Jun 25, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 15 9:18 PM | FRED ASLAN | Proposed Sale | 12,749 | $3.30 | $42.1K | — | View → |
| Nov 17, 2025 | Nov 17 9:29 PM | FRED ASLAN | Proposed Sale | 6,375 | $3.25 | $20.7K | — | View → |
| Oct 17, 2025 | Oct 17 8:17 PM | FRED ASLAN | Proposed Sale | 25,500 | $2.77 | $70.6K | — | View → |
| Aug 15, 2025 | Aug 15 8:24 PM | FRED ASLAN | Proposed Sale | 25,500 | $2.70 | $68.8K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 19 12:11 PM | Gines Diego MirallesPresident & Head of R&D | Grant/Award | 232,500 | $9.22 | 232,500(D) | View → |
| May 11, 2026 | May 13 9:45 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,170,138 | $0.0001 | 2,170,138(I) | View → |
| Feb 18, 2026 | Feb 20 2:50 AM | Elaine K. SorgDirector | Grant/Award | 27,500 | $4.15 | 27,500(D) | View → |